שימוש בתרופה מחוץ לשימוש המאושר
להגדלת הטקסט להקטנת הטקסט-
נושא
|
מספר מערכת
987012575085405171
-
נשמר בהצלחההפריט קיים באזור האישישגיאההכנסו לחשבון כדי לשמור
מידע על הזהות:
שם ראשי (עברית)
שימוש בתרופה מחוץ לשימוש המאושר
שם ראשי (לועזית)
Off-label drug use
שם ראשי (ערבית)
استخدام العقاقير خارج التسمية الطبية
רמיזות
Extra-label drug use
Off-label prescribing
נושא איתו מזוהה
Drug utilization
Drugs Prescribing
MARC
MARC
מזהים נוספים
Wikidata:
Q119697
Library of congress:
sh2019003668
מקורות מידע
- Work cat: United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations. Off-label drug use and FDA review of supplemental drug applications, 1998:p. 1 (off-label use of prescription medications; use of a drug for additional indications, additional patients, or at a different dosage level than originally approved; extra-label drug use; off-label use; off-label drug)
- MeSH, May 7, 2019(off-label use: the practice of prescribing or using a drug or a vaccine outside the scope of the drug's official approved label as designated by a regulatory agency concerning the treatment of a particular disease or condition; entry terms: dose-sparing drug use, fractional dose drug use, off-label prescribing, reduced-dose drug use, unlabeled indication; see also: drug approval, drug labeling, drug utilization)
- Merriam-Webster online, May 7, 2019(off-label; of, relating to, or being a drug used to treat a condition for which it has not been officially approved)
- The journal of law, medicine & ethics, Fall 2009:p. 476 (off-label prescribing; off-label use)
- Mayo Clinic. Mayo Clinic proceedings, Oct. 2012:p. 982 (off-label drug use; OLDU) p. 989 (practitioners are typically forced to use medications in an off-label manner to treat rare, or orphan, diseases; orphan drugs are often a subtype of OLDU)